Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPARγ and TNFα Signaling

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pagnotta, Stefano Maria ^a   Laudanna, Carmelo ^a   Pancione, Massimo ^a   Sabatino, Lina ^a   Votino, Carolina ^a   Remo, Andrea ^c   Cerulo, Luigi ^a,b   Zoppoli, Pietro ^d   Manfrin, Erminia ^e   Colantuoni, Vittorio ^a   Ceccarelli, Michele ^a,b  

^a UNIVERSITY OF SANNIO   (Italy)

^b Grande Ospedale Metropolitano   (Italy)

^c Hospital Mater Salutis   (Italy)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

AKAP12 GENE; ALGORITHM; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DBCLD2 GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SIGNATURE FINDER ALGORITHM; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; NT5E GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPON1 GENE; SURVIVAL RATE; SURVIVAL TIME; WESTERN BLOTTING;

5'-NUCLEOTIDASE; AGED; ALGORITHMS; CELL ADHESION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; EXTRACELLULAR MATRIX; GPI-LINKED PROTEINS; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR GAMMA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887565685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072638     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. J Cancer 127: 2893-2917. PubMed: 21351269.
2. Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, et al. (2012) ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut 61: 1560-1567. doi:10.1136/gutjnl-2011-301179. PubMed: 22213796.
3. Cancer Genome Atlas Network (2012). Comprehensive Molecular Characterization of Human Colon and Rectal Cancer. Nature 487: 330-337.
4. Culhane AC, Schröder MS, Sultana R, Picard SC, Martinelli EN, et al. (2012) GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res 40(D1):: D1060-D1066. doi:10.1093/nar/gkr901.
5. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer. N Engl J Med 356: 11-20. doi:10.1056/NEJMicm064050. PubMed: 17202451.
6. Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, et al. (2009) Prognostic gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci U S A 106: 2824-2828. doi:10.1073/pnas.0809444106. PubMed: 19196983.
7. Sveen A, Ågesen TH, Nesbakken A, Meling GI, Rognum TO, et al. (2012) ColoGuidePro: A prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res 18(21):: 6001-6010. doi:10.1158/1078-0432.CCR-11-3302. PubMed: 22991413.
8. Guyon I, Elisseeff A, (2003) An introduction to variable and feature selection. J Mach Learn Res 3: 1157-1182.
9. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968. doi:10.1053/j.gastro.2009.11.005. PubMed: 19914252.
10. Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, et al. (2011) Epigenetic silencing of Peroxisome Proliferator-Activated Receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome. PLOS ONE 5(12):: e14229.
11. Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, et al. (2010) Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol: pp. l41: 867-876.
12. Schwarz G, (1978) Estimating the dimension of a model. Ann Stat 6: 461-464. doi:10.1214/aos/1176344136.
13. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, et al. (2012) Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22(5):: 571-584. doi:10.1016/j.ccr.2012.08.013. PubMed: 23153532.
14. Liu W, Guan M, Hu T, Gu X, Lu Y, (2011) Re-Expression of AKAP12 Inhibits Progression and Metastasis Potential of Colorectal Carcinoma In Vivo and In Vitro. PLOS ONE 6(8):: e24015. doi:10.1371/journal.pone.0024015. PubMed: 21918680.
15. Croft M, Benedict CA, Ware CF, (2013) Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov 12(2):: 147-168. doi:10.1038/nrd3930. PubMed: 23334208.
16. Terzić J, Grivennikov S, Karin E, Karin M, (2010) Inflammation and colon cancer. Gastroenterology 138(6): 2101-2114.e5.
17. Spychala J, Kitajewski J, (2004) Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Exp Cell Res 296(2):: 99-108. doi:10.1016/j.yexcr.2003.11.001. PubMed: 15149841.
18. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, et al. (2002) Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110(7):: 993-1002. doi:10.1172/JCI0215337. PubMed: 12370277.
19. Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, et al. (2012) UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectalcancer progression. Oncogene 31(49):: 5061-5072. doi:10.1038/onc.2012.3. PubMed: 22286757.
20. Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A, (2002) Characteristics of the peroxisome proliferator activated receptor gamma (PPARγ) ligand induced apoptosis in colon cancer cells. Gut 50(5):: 658-664. doi:10.1136/gut.50.5.658. PubMed: 11950812.
21. Wang J, Lv X, Shi J, Hu X, Du Y, (2011) Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells. Biomed Environ Sci 24(4):: 391-399. PubMed: 22108328.
22. Nauert JB, Klauck TM, Langeberg LK, Scott JD, (1997) Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 7(1):: 52-56. doi:10.1016/S0960-9822(06)00027-3. PubMed: 9000000.
23. Wang HY, Tao J, Shumay E, Malbon CC, (2006) G-protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol 85(7):: 643-650. doi:10.1016/j.ejcb.2005.12.003. PubMed: 16442664.
24. Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, et al. (2012) Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. J Surg Oncol 105(4):: 381-386. doi:10.1002/jso.22135. PubMed: 22052684.
25. Liu W, Gong J, Hu J, Hu T, Sun Y, et al. (2011) Quantitative Assessment of AKAP12 Promoter Methylation in Human Prostate Cancer Using Methylation-sensitive High-resolution Melting: Correlation With Gleason Score. Urology 77(4):: 1006.e1-1006.e7. PubMed: 21310466.
26. Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, et al. (2012) Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics 7(12):: 1355-1367. doi:10.4161/epi.22562. PubMed: 23079744.
27. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, et al. (2004) AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 16(23):: 7095-7103. PubMed: 15258566.
28. Burstyn-Cohen T, Tzarfaty V, Frumkin A, Feinstein Y, Stoeckli E, et al. (1999) F-Spondin is required for accurate pathfinding of commissural axons at the floor plate. Neuron 23(2):: 233-246. doi:10.1016/S0896-6273(00)80776-X. PubMed: 10399931.
29. Pyle-Chenault RA, Stolk JA, Molesh DA, Boyle-Harlan D, McNeill PD, et al. (2005) VSGP/F-spondin: a new ovarian cancer marker. Tumour Biol 26(5):: 245-257. doi:10.1159/000087379. PubMed: 16103746.
30. Cheng YC, Liang CM, Chen YP, Tsai IH, Kuo CC, et al. (2009) F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression. J Neurochem 110(3):: 947-955. doi:10.1111/j.1471-4159.2009.06186.x. PubMed: 19549008.
31. Gritsenko PG, Ilina O, Friedl P, (2012) Interstitial guidance of cancer invasion. J Pathol 226(2):: 185-199. doi:10.1002/path.3031. PubMed: 22006671.
32. Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F, (2012) Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut 61(10):: 1465-1472. doi:10.1136/gutjnl-2011-300810. PubMed: 22071959.
33. Kim M, Lee KT, Jang HR, Kim JH, Noh SM, et al. (2008) Epigenetic Down-Regulation and Suppressive Role of DCBLD2 in Gastric Cancer Cell Proliferation and Invasion. Mol Cancer Res 6(2):: 222-230. doi:10.1158/1541-7786.MCR-07-0142. PubMed: 18314483.
34. Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R, (2012) Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev 31(1-2):: 295-321. doi:10.1007/s10555-012-9346-z. PubMed: 22366781.
35. Guo X, Nie L, Esmailzadeh L, Zhang J, Bender JR, et al. (2009) Endothelial and Smooth Muscle-derived Neuropilin-like Protein Regulates Platelet-derived Growth Factor Signaling in Human Vascular Smooth Muscle Cells by Modulating Receptor Ubiquitination. J Biol Chem 284(43):: 29376-29382. doi:10.1074/jbc.M109.049684. PubMed: 19696027.
36. Stagg J, Beavis PA, Divisekera U, Liu MC, Möller A, et al. (2012) CD73-deficient mice are resistant to carcinogenesis. Cancer Res 72(9):: 2190-2196. doi:10.1158/0008-5472.CAN-12-0420. PubMed: 22396496.
37. Wu XR, He XS, Chen YF, Yuan RX, Zeng Y, et al. (2012) High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol 106(2):: 130-137. doi:10.1002/jso.23056. PubMed: 22287455.
38. Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, et al. (2010) Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol 41(6):: 867-876. doi:10.1016/j.humpath.2009.09.019. PubMed: 20129645.
39. Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, et al. (2009) Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. Hum Pathol 40(5):: 714-725. doi:10.1016/j.humpath.2008.08.019. PubMed: 19121846.
40. Ye J, (2008) Regulation of PPARgamma function by TNF-alpha. Biochem Biophys Res Commun 374(3):: 405-408. doi:10.1016/j.bbrc.2008.07.068. PubMed: 18655773.